Valuation Mega Lifesciences Thailand S.E.

Stocks

End-of-day quote Thailand S.E. 30/10/2026			5-day change	1st Jan Change
33.00 ^THB	+0.76%		-4.35%	-1.49%

08-24	Mega Lifesciences Public Company Limited, Q2 2026 Earnings Call, Aug 14, 2026
08-13	Mega Lifesciences Public Company Limited Announces Declaration of Interim Dividend for Period from 01 January 2026 to 30 June 2026, Payable on 11 September 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	44,029	40,760	35,093	28,990	29,208	28,772	-	-
Change	-	-7.43%	-13.9%	-17.39%	0.75%	-1.49%	-	-
Enterprise Value (EV) ¹	41,666	38,309	32,456	25,464	25,051	24,155	24,052	23,718
Change	-	-8.06%	-15.28%	-21.54%	-1.62%	-3.58%	-0.43%	-1.39%
P/E	22.6x	18.2x	17.6x	14.4x	15.3x	12.6x	11.6x	10.9x
PBR	5.5x	4.64x	3.77x	2.94x	2.86x	2.62x	2.6x	2.51x
PEG	-	1.2x	-1.6x	16.49x	-2.95x	0.7x	1.25x	1.64x
Capitalization / Revenue	3.08x	2.6x	2.24x	1.89x	2.06x	2.01x	1.86x	1.77x
EV / Revenue	2.91x	2.44x	2.07x	1.66x	1.77x	1.69x	1.55x	1.46x
EV / EBITDA	17.2x	13x	10.2x	6.78x	8.73x	7.63x	6.8x	6.29x
EV / EBIT	18.1x	14.3x	11.2x	7.56x	9.69x	8.62x	7.56x	7.01x
EV / FCF	16.2x	22.6x	19.6x	11.8x	11.9x	10.6x	11.7x	10.9x
FCF Yield	6.18%	4.42%	5.09%	8.46%	8.41%	9.46%	8.51%	9.19%
Dividend per Share ²	1.06	1.61	1.65	1.6	1.6	1.782	1.909	2.039
Rate of return	2.1%	3.44%	4.1%	4.81%	4.78%	5.4%	5.78%	6.18%
EPS ²	2.23	2.57	2.29	2.31	2.19	2.61	2.851	3.041
Distribution rate	47.5%	62.6%	72.1%	69.3%	73.1%	68.3%	66.9%	67%
Net sales ¹	14,301	15,686	15,681	15,344	14,147	14,330	15,499	16,271
EBITDA ¹	2,426	2,953	3,190	3,756	2,868	3,167	3,537	3,768
EBIT ¹	2,305	2,681	2,904	3,370	2,585	2,803	3,181	3,384
Net income ¹	1,947	2,242	1,993	2,012	1,912	2,243	2,486	2,652
Net Debt ¹	-2,363	-2,451	-2,636	-3,525	-4,156	-4,617	-4,720	-5,053
Reference price ²	50.50	46.75	40.25	33.25	33.50	33.00	33.00	33.00
Nbr of stocks (in thousands)	871,870	871,870	871,870	871,870	871,870	871,870	-	-
Announcement Date	23/02/22	25/02/23	22/02/24	24/02/25	24/02/26	-	-	-

¹THB in Million²THB

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	40.35x	13.85x	30.26x	0.5%	1,224B
JOHNSON & JOHNSON	40.28x	6.76x	19.02x	1.94%	662B
ABBVIE INC.	38.08x	8.51x	17.61x	2.36%	514B
ROCHE HOLDING AG	21.65x	5.25x	13.07x	2.49%	388B
MERCK & CO., INC.	106.67x	5.95x	25.48x	2.33%	361B
NOVARTIS AG	22.86x	5.89x	14.22x	2.75%	302B
ASTRAZENECA PLC	22.82x	4.6x	13.15x	1.92%	271B
AMGEN INC.	29.23x	7.45x	13.34x	2.19%	249B
GILEAD SCIENCES, INC.	-47.64x	7.37x	28.55x	1.99%	205B
Average	30.48x	7.29x	19.41x	2.05%	464.09B
Weighted average by Cap.	36.66x	8.71x	21.55x	1.73%